ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2267

Explainable Machine Learning to Predict Hospitalized Infection in Patients with Systemic Lupus Erythematosus

Hsin-Hua Chen1 and Wen-Nan Huang2, 1Taichung Veterans General Hospital, Taichung, Taiwan, 2Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Veterans General Hospital, College of Medicine National Chung Hsing University, Department of Business Administration, Ling-Tung University, Taichung, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

Meeting: ACR Convergence 2023

Keywords: Epidemiology, Infection, risk assessment, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) have a 1.85-fold higher risk of all-cause mortality and a 2.74 fold higher risk of infection-related mortality compared with controls. In addition, infection is responsible for up to 45% of hospitalization and 65.8% of death. However, few studies had developed a prediction tool for hospitalized infection in patients with SLE using electronic medical records (EMR). Therefore, we aimed to develop predictive models for hospitalized infection in patients with SLE in a medical center in central Taiwan.

Methods: Using EMR data of patients with SLE from the Taichung Veterans General Hospital during the period of 2012–2022, we conducted five machine learning (ML) models, including extreme boosting (XGBoost), random forest (RF), logistic regression (LR), support vector machine (SVM) and K nearest neighbor (KNN). The ratio between training/testing was 80/20. We used the SHAP summary plot to illustrate the strength and the direction of associations between key features and 30-day risk of hospitalized infection. We performed the receiver operating characteristic (ROC) analysis, calibration curve and decision curve analysis to determine discrimination, accuracy and applicability of the predictive ML modes in the testing datasets.

Results: Figure 1 showed the flowchart of subject enrollment. A total of 5368 patients with SLE with at least two ambulatory visits were included. Table 1 summarizes characteristics of patients with and without hospitalized infection. We finally included 28 features of four domains (demographics, laboratory data within one year before the index date, comorbidities in prior one year, and cumulative dose of medications in prior 3 months [9 months for rituximab]) based on feature importance in the ML models (Fig 2A). Fig 2B showed cumulative relative feature importance of top 28 features categorized by main clinical domains in predicting 30-day hospitalized infection. As shown in Fig 2C, XGBoost showed the best performance among the five ML models with a sensitivity of 83.15%, a specificity of 94.09%, an accuracy of 93.11% and an area under curve (AUC) in ROC analysis of 95.9% in the testing datasets. Because laboratory data domain provides the largest portion of feature importance, after exclusion of 11 medication domain features, we re-conducted ML models using 15 laboratory data domain features and 2 demographic domain features and found the XGBoost model still revealed the best performance with an accuracy of 91.91% and an AUC in ROC of 93.94% (data not shown).

Conclusion: We developed explainable ML models to predict hospitalized prediction in patients with SLE using 10-year EMR data from a medical center in Taiwan.

Supporting image 1

Fig 1. Flowchart of study subjects enrollment.

Supporting image 2

Table 1. Characteristics of patients with SLE with and without hospitalized infection.

Supporting image 3

Fig 2. XGBoost feature importance (2A), cumulative relative feature importance of top 28 features categorised by main clinical domains (2B) and performance of various machine learning models (2C).


Disclosures: H. Chen: None; W. Huang: Novartis, 12, Received PI fee.

To cite this abstract in AMA style:

Chen H, Huang W. Explainable Machine Learning to Predict Hospitalized Infection in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/explainable-machine-learning-to-predict-hospitalized-infection-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/explainable-machine-learning-to-predict-hospitalized-infection-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology